Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

A 25-year-old woman in China has had her Type 1 diabetes reversed through a groundbreaking new stem cell therapy treatment! As you can imagine, this represents a historic turning point in medical ...

Crisis Looms in Diabetes Care: New Study from CCS Reveals Critical Gaps in Patient Education as Provider Burnout Intensifies ...

The ByramConnect platform offers Byram diabetes customers access to the Welldoc App, which provides their care teams a holistic view of their condition by combining patient-tracked health data and ...

Explore a methodological approach for discovering the emotional patient journey through patient insights. Understand the importance of emotional connections in healthcare.

Parma woman was among the first patients in Northeast Ohio to receive the first FDA-approved drug, Tzield that can delay the onset of Type 1 diabetes and the need for insulin for up to three years.

Digital health innovation (DHI) is a growing category of technologies that connect healthcare stakeholders and improve patient experiences and outcomes.

Say goodbye to multiple appointments! At Singapore's Diabetes and Metabolism Centre, expert care for diabetes and metabolic conditions is all in one place.

Effective targets for systolic blood-pressure control in patients with type 2 diabetes are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated systolic blood press ...

World-First Stem Cell Treatment Reverses Diabetes for a Patient in China, Study Suggests Scientists converted the patient’s own cells into blood sugar-regulating cell clusters before injecting ...